These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14032722)

  • 1. Synthesis and biological properties of 1-desamino-8-lysine-vasopressin.
    KIMBROUGH RD; CASH WD; BRANDA LA; CHAN WY; DU VIGNEAUD V
    J Biol Chem; 1963 Apr; 238():1411-4. PubMed ID: 14032722
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional and systemic haemodynamic effects of some vasopressins: structural features of the hormone which prolong activity.
    Cort JH; Albrecht I; Nováková J; Mulder JL; Jost K
    Eur J Clin Invest; 1975 Apr; 5(2):165-75. PubMed ID: 168085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological properties of 1-acetyl-8-lysine-vasopressin.
    CASH WD; SMITH BL
    J Biol Chem; 1963 Mar; 238():994-7. PubMed ID: 14019074
    [No Abstract]   [Full Text] [Related]  

  • 4. Ion-exchange chromatography of oxytocin, arginine-vasopressin, and lysine-vasopressin.
    TAYLOR SP
    Proc Soc Exp Biol Med; 1954 Feb; 85(2):226-8. PubMed ID: 13155555
    [No Abstract]   [Full Text] [Related]  

  • 5. A COMPARISON OF THE EFFECTS OF 8-LYSINE-VASOPRESSIN, 1-DEAMINO-8-LYSINE-VASOPRESSIN AND 1-ACETYL-8-LYSINE-VASOPRESSIN ON THE BLOOD GLUCOSE LEVEL IN RABBITS.
    CASH WD; KAPLAN MH
    Endocrinology; 1964 May; 74():803-4. PubMed ID: 14168572
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of arginine-vasopressin and lysine-vasopressin on plasma 17-hydroxycorticosteroid levels in man.
    MCDONALD RK; WEISE VK
    Proc Soc Exp Biol Med; 1956 Jul; 92(3):481-3. PubMed ID: 13359440
    [No Abstract]   [Full Text] [Related]  

  • 7. INACTIVATION OF ARGININE- AND LYSINE-VASOPRESSIN BY SLICES FROM DIFFERENT ZONES OF THE RAT KIDNEY AND BY RAT LIVER SLICES.
    THORN NA; WILLUMSEN NB
    Acta Endocrinol (Copenh); 1963 Dec; 44():545-62. PubMed ID: 14082543
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of some activities of arginine vasopressin and lysine vasopressin on kidney function in conscious dogs.
    ALI MN
    Br J Pharmacol Chemother; 1958 Jun; 13(2):131-7. PubMed ID: 13536276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ACTIONS OF ACTH AND LYSINE-VASOPRESSIN ON SYNTHESIS AND RELEASE OF CORTICOSTERONE IN THE RAT--STUDY IN VITRO].
    MIALHE-VOLOSS C; KOCH B; DUCOMMUN P; FORTIER C
    Rev Can Biol; 1964 Dec; 23():469-72. PubMed ID: 14257893
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of synthetic lysine-vasopressin on plasma hydrocortisone levels in man.
    MCDONALD RK; PATRICK RW; WEISE VK
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):348-9. PubMed ID: 13379507
    [No Abstract]   [Full Text] [Related]  

  • 11. Dissimilarity between arginine-and lysine vasopressin in rat pressor assays.
    NIELSEN AT
    Acta Endocrinol (Copenh); 1960 Oct; 35():299-311. PubMed ID: 13728936
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysine-vasotocin, a synthetic analogue of the posterior pituitary hormones containing the ring of oxytocin and the side chain of lysine-vasopressin.
    KIMBROUGH RD; DU VIGNEAUD V
    J Biol Chem; 1961 Mar; 236():778-80. PubMed ID: 13755994
    [No Abstract]   [Full Text] [Related]  

  • 13. DIABETES INSIPIDUS. DIFFICULTIES IN DIAGNOSIS AND TREATMENT; USE OF SYNTHETIC LYSINE-8 VASOPRESSIN IN PATIENTS INTOLERANT OF OTHER THERAPY.
    EISENBERG E
    Calif Med; 1965 May; 102(5):353-8. PubMed ID: 14290932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOME BIOLOGICAL AND CHEMICAL PROPERTIES OF A LYSINE- VASOPRESSIN DIMER.
    SCHALLY AV; GUILLEMIN R
    J Biol Chem; 1964 Apr; 239():1038-41. PubMed ID: 14165903
    [No Abstract]   [Full Text] [Related]  

  • 15. DIABETES INSIPIDUS. TREATMENT WITH 8-LYSINE VASOPRESSIN IN A NASAL SPRAY.
    CHIRMAN SB; KINSELL LW
    Calif Med; 1964 Jul; 101(1):1-3. PubMed ID: 14179526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the purification of lysine vasopressin from hog pituitary glands.
    DU VIGNEAUD V; WARD DN
    J Biol Chem; 1956 Oct; 222(2):951-8. PubMed ID: 13367062
    [No Abstract]   [Full Text] [Related]  

  • 17. SYNTHETIC LYSINE VASOPRESSIN NASAL SPRAY IN THE TREATMENT OF DIABETES INSIPIDUS.
    MOSES AM
    Clin Pharmacol Ther; 1964; 5():422-7. PubMed ID: 14200290
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticotropin releasing activity of synthetic lysine vasopressin.
    HEARN WR; WEBER EJ; RANDOLPH PW; BARKS NE
    Proc Soc Exp Biol Med; 1961 Jul; 107():515-7. PubMed ID: 13712598
    [No Abstract]   [Full Text] [Related]  

  • 19. ACTH releasing activity in vivo of a CRF preparation and lysine vasopressin.
    GUILLEMIN R; DEAR WE; NICHOLS B; LIPSCOMB HS
    Proc Soc Exp Biol Med; 1959 May; 101(1):107-11. PubMed ID: 13658207
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship of radioimmunoassay to bioassay: in vitro studies with synthetic lysine vasopressin in aqueous solution inactivated by heat.
    Lembøl HL
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):465-73. PubMed ID: 581018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.